Chemokine CXCL10

Description: 
CXCL10 is a pro-inflammatory cytokine secreted in response to IFN-γ by a variety of cells. Binding of CXCL10 to its receptor, CXCR3, promotes the migration of T cells and monocytes, regulating the immune response. CXCL10 is a biomarker of T cell activity.
Clinical details: 
In many inflammatory diseases, immune system dysfunction causes CXCL10 to be raised resulting in inflammation. CXCL10 has been shown to be raised in inflammatory disease, such as type 1 diabetes, rheumatoid arthritis, cryoglobulinaemia, SLE, Sjögren’s syndrome, and Behçet’s Disease. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new strain of coronavirus which causes the coronavirus disease known as COVID-19 7. Severe fever and pneumonia leading to “cytokine storm” causes acute respiratory distress syndrome (ARDS) in approximately 20% of patients and is associated with severe disease. Circulating CXCL10 has been shown to be raised in COVID-19, suggesting T cell activation. Raised CXCL10 is associated with disease severity and has been suggested as a biomarker of COVID-19 severity and outcome.
Reference range: 

38 - 361

Synonyms or keywords: 
IP10, Covid-19
Units: 
pg/mL
Sample type and Volume required: 
SST (yellow top)
Turnaround time: 
7 days
Special sample instructions: 

Allow samples to clot for 30 minutes after being taken. Samples must then be centrifuged and frozen immediately. External requestors must send frozen samples on dry ice.

Storage and transport: 
Samples stored at -30°C
Time limit for extra tests: 
A separate sample is required for extra tests
Contacts:
Diagnostic Immunology and Allergy Department at King's College Hospital
General Enquiry : 020 3299 8752 / 020 3299 1171
King's College Hospital
Bessemer Wing - 1st Floor
Denmark Hill
London SE5 9RS
For clinical advice or interpretation of results, please contact the laboratory in the first instance.

Print as a PDF

Last updated: 03/07/2022